|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Jul―30 |
Longitudinal Importance of the Soluble Receptor for Advanced Glycation End-Products in Non-intubated Hospitalized Patients with COVID-19 Pneumonia |
Katherine D. Wick, Lianne Siegel, Cathryn Oldmixon, Jens D. Lundgren, B. Taylor Thompson, Chayse Jones, et al. (+2) Carolyn Leroux, Michael A. Matthay |
2 |
[GO] |
2024―Jun―11 |
Activation of Alveolar Epithelial ER Stress by β-Coronavirus Infection Disrupt Surfactant Homeostasis in Mice: Implications for Covid-19 Respiratory Failure |
Aditi Murthy, Luis R. Rodriguez, Thalia Dimopoulos, Sarah Bui, Swati Iyer, Katrina Chavez, et al. (+10) Yaniv Tomer, Valsamma Abraham, Charlotte Cooper, David M. Renner, Jeremy B. Katzen, Ian D. Bentley, Samir N. Ghadiali, Joshua A. Englert, Susan R. Weiss, Michael F. Beers |
3 |
[GO] |
2024―Feb―27 |
Repetitive Sulfur Dioxide Exposure in Mice Models Post-Deployment Respiratory Syndrome |
Sergey S. Gutor, Rodrigo I. Salinas, David S. Nichols, Julia M. R. Bazzano, Wei Han, Jason J. Gokey, et al. (+8) Georgii Vasiukov, James D. West, Dawn C. Newcomb, Anna E. Dikalova, Bradley W. Richmond, Sergey I. Dikalov, Timothy S. Blackwell, Vasiliy V. Polosukhin |
4 |
[GO] |
2024―Jan―30 |
Aryl hydrocarbon receptor activation alters immune cell populations in the lung and bone marrow during coronavirus infection |
Alicia M. Healey, Kristina N. Fenner, Colleen T. O'Dell, B. Paige Lawrence |
5 |
[GO] |
2023―Dec―26 |
Does Vaping Increase the Likelihood of SARS-CoV-2 Infection? Paradoxically Yes and No |
Rattapol Phandthong, Man Wong, Ann Song, Teresa Martinez, Prue Talbot |
6 |
[GO] |
2023―Nov―07 |
The alveolar fibroproliferative response in moderate to severe COVID-19-related acute respiratory distress syndrome and one-year follow up |
Shiqi Zhang, Leonoor S. Boers, Justin de Brabander, Laura B. van den Heuvel, Siebe G. Blok, Robert F.J. Kullberg, et al. (+10) Barbara S. Smids-Dierdorp, Tamara Dekker, Hella L. Aberson, Lilian J. Meijboom, Alexander P.J. Vlaar, Leo Heunks, Esther J. Nossent, Tom van der Poll, Lieuwe D.J. Bos, JanWillem Duitman |
7 |
[GO] |
2023―Oct―24 |
Exercise ventilatory response after COVID-19: comparison between ambulatory and hospitalized patients |
Ivan Guerreiro, Aurélien Bringard, Mayssam Nehme, Idris Guessous, Lamyae Benzakour, Alix Juillet De Saint-Lager-Lucas, et al. (+2) Anna Taboni, Frédéric Lador |
8 |
[GO] |
2023―Oct―03 |
Chronic alcohol use primes bronchial cells for altered inflammatory response and barrier dysfunction during SARS-CoV-2 infection |
Kristen F. Easley, R. Clayton Edenfield, Megan Jane Lott, Ryan C. Reed, Jayasri Das Sarma, Ashish J. Mehta, et al. (+10) Bashar S. Staitieh, Erin K. Lipp, In Ki Cho, Scott K. Johnson, Cheryl A. Jones, Anne-Gaelle Bebin-Blackwell, Joshua M. Levy, S. Mark Tompkins, Charles A. Easley 4th, Michael Koval |
9 |
[GO] |
2023―Mar―28 |
SARS-CoV-2 E protein induces Toll like receptor 2-mediated neonatal lung injury in a model of COVID-19 viremia that is rescued by the glucocorticoid ciclesonide |
Heather L. Menden, Sherry M. Mabry, Aparna Venkatraman, Sheng Xia, Donald B. DeFranco, Wei Yu, Venkatesh Sampath |
10 |
[GO] |
2023―Feb―21 |
Mucociliary Clearance Augmenting Drugs Block SARS-Cov-2 Replication in Human Bronchial Epithelial Cells |
Javier Campos-Gomez, Courtney Fernandez Petty, Marina Mazur, Liping Tang, George M. Solomon, Reny Joseph, et al. (+7) Qian Li, Jacelyn E. Peabody Lever, Shah Saddad Hussain, Kevin S. Harrod, Ezinwanne E. Onuoha, Harrison Kim, Steven M. Rowe |
11 |
[GO] |
2023―Jan―31 |
The SARS-CoV-2 Spike S1 Protein Induces Global Proteomic Changes in ATII-Like Rat L2 Cells that are attenuated by Hyaluronan |
James A. Mobley, Adam Molyvdas, Kyoko Kojima, Israr Ahmad, Tamas Jilling, Jian-Liang Li, et al. (+2) Stavros Garantziotis, Sadis Matalon |
12 |
[GO] |
2022―Nov―08 |
Call for Papers: "In it for the long haul: understanding the lasting impact of COVID-19 on lung health and disease" |
Nathan W. Bartlett, Julie A. Bastarache, Wolfgang M. Kuebler, Eric P. Schmidt |
13 |
[GO] |
2022―Oct―11 |
Pneumonia in the third year of the pandemic: One eye on the pathogens, the other on the host |
Christina Julius, Mathias W Pletz, Jan Rupp, Martin Witzenrath, Grit Barten-Neiner, Gernot Rohde |
14 |
[GO] |
2022―Oct―04 |
Competitive Cleavage of SARS-CoV-2 Spike Protein and ENaC by Plasmin as a Potential Mechanism for COVID-19 Infection |
Yapeng Hou, Tong Yu, Tingyu Wang, Yan Ding, Yong Cui, Hongguang Nie |
15 |
[GO] |
2022―Aug―16 |
World Lung Day: Impact of "The big 5 lung diseases" in the context of COVID-19 |
Mark Cohen, Stephanie M. Levine, Heather J. Zar |
16 |
[GO] |
2022―Jun―28 |
Exploring antiviral and anti-inflammatory effects of thiol drugs in COVID-19 |
Kritika Khanna, Wilfred Raymond, Jing Jin, Annabelle R. Charbit, Irina Gitlin, Monica Tang, et al. (+15) Adam D. Werts, Edward G. Barrett, Jason M. Cox, Sharla M. Birch, Rachel Martinelli, Hannah S. Sperber, Sergej Franz, Thomas Duff, Markus Hoffmann, Anne Marie Healy, Stefan Oscarson, Stefan Pöhlmann, Satish K. Pillai, Graham Simmons, John V. Fahy |
17 |
[GO] |
2022―Jun―14 |
Absolute quantification of plasma mitochondrial DNA by droplet digital PCR marks COVID-19 severity over time during intensive care unit admissions |
Mark L. Hepokoski, Mazen Faris Odish, Michael T. Lam, Nicole G. Coufal, Mark L. Rolfsen, Gerald S. Shadel, et al. (+15) Alexandra G. Moyzis, Alva G. Sainz, Puja G. Takiar, Sagar Patel, Austin J. Leonard, Negin Samandari, Emily Hansen, Samantha Trescott, Celina Nguyen, Kristen Jepsen, Gary Cutter, Mark N. Gillespie, Roger G. Spragg, Roman Sasik, Joachim H. Ix |
18 |
[GO] |
2022―May―24 |
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness |
Eric D. Morrell, Pavan K. Bhatraju, Neha A. Sathe, Jonathan Lawson, Linzee Mabrey, Sarah E. Holton, et al. (+24) Scott R. Presnell, Alice Wiedeman, Carolina Acosta-Vega, Mallorie A. Mitchem, Ted Liu, Xin-Ya Chai, Sharon Sahi, Carolyn Brager, Marika Orlov, Sana S. Sakr, Anthony Sader, Dawn M. Lum, Neall Koetje, Ashley Garay, Elizabeth Barnes, Gail Cromer, Mary K. Bray, Sudhakar Pipavath, Susan L. Fink, Laura Evans, S. Alice Long, T. Eoin West, Mark M. Wurfel, Carmen Mikacenic |
19 |
[GO] |
2022―Mar―23 |
Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease |
Yang Peng, Zhao-Ni Wang, Shi-Ying Chen, Ai-Ru Xu, Zhang-Fu Fang, Jing Sun, et al. (+8) Zi-Qing Zhou, Xiao-Tao Hou, Lai-Jian Cen, Jian-Juan Ma, Jin-Cun Zhao, Wei-Jie Guan, De-Yun Wang, Nan-Shan Zhong |
20 |
[GO] |
2022―Feb―02 |
Woodsmoke particle exposure prior to SARS-CoV-2 infection alters antiviral response gene expression in human nasal epithelial cells in a sex-dependent manner |
Stephanie A Brocke, Grant T Billings, Sharon Taft-Benz, Neil E. Alexis, Mark T Heise, Ilona Jaspers |
21 |
[GO] |
2022―Jan―12 |
Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection |
Ruobing Wang, Adam J. Hume, Mary Lou Beermann, Chantelle Simone-Roach, Jonathan Lindstrom-Vautrin, Jake Le Suer, et al. (+13) Jessie Huang, Judith Olejnik, Carlos Villacorta-Martin, Esther Bullitt, Anne Hinds, Mahboobe Ghaedi, Stuart Rollins, Rhiannon B. Werder, Kristine M. Abo, Andrew A. Wilson, Elke Mühlberger, Darrell N. Kotton, Finn J. Hawkins |
22 |
[GO] |
2022―Jan―11 |
Is there a shift of the oxygen-hemoglobin dissociation curve in COVID-19? |
Thomas Gille, Lucile Sesé, Eric Aubourg, Jean-François Bernaudin, Jean-Paul Richalet, Carole Planès |
23 |
[GO] |
2021―Nov―17 |
Ending AIDS and Stopping Pandemics Through Closing Inequalities |
Matthew M Kavanagh, Helena Nygren Krug |
24 |
[GO] |
2021―Oct―13 |
Control and challenge of COVID-19: lesson from China experience |
Na Zhu, Wenjie Tan |
25 |
[GO] |
2021―Sep―29 |
COVID-19 and COPD: Lesson beyond the pandemic |
David MG Halpin, Claus F Vogelmeier, Alvar Agusti |
26 |
[GO] |
2021―Sep―09 |
Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia |
Mada Ghanem, Méline Homps-Legrand, Marc Garnier, Lise Morer, Tiphaine Goletto, Justine Frija-Masson, et al. (+15) Paul-Henri Wicky, Pierre Jaquet, Catherine Bancal, Margarita Hurtado-Nedelec, Luc de Chaisemartin, Madeleine Jaillet, Arnaud A. Mailleux, Christophe Quesnel, Nicolas Poté, Marie-Pierre Debray, Etienne de Montmollin, Catherine Neukirch, Raphael Borie, Camille Taillé, Bruno Crestani |
27 |
[GO] |
2021―Sep―07 |
The increased hemoglobin oxygen affinity in COVID-19 |
Dominik J. Vogel, Federico Formenti, Luigi Camporota |
28 |
[GO] |
2021―Aug―18 |
A Pediatric Perspective on World Sepsis Day in 2021 - Leveraging Lessons from The Pandemic to Reduce the Global Pediatric Sepsis Burden? |
Luregn J Schlapbach, Konrad Reinhart, Niranjan Kissoon |
29 |
[GO] |
2021―Aug―11 |
Lung Health in Africa: challenges and opportunities in the context of COVID-19 |
Obianuju B Ozoh, Bertrand Hugo Mbatchou Ngahane, Heather J Zar, Refiloe Masekela, Jeremiah Chakaya, Joseph Aluoch |
30 |
[GO] |
2021―Jul―07 |
Erythrocytes Identify Complement Activation in Patients with COVID-19 |
LK Metthew Lam, John Patrick Reilly, Ann H Rux, Sophia Murphy, Leticia Kuri-Cervantes, Ariel Weisman, et al. (+9) Caroline AG Ittner, M. Betina Pampena, Michael Betts, E John Wherry, Wen-Chao Song, John D Lambris, Nuala J Meyer, Douglas B Cines, Nilam S. Mangalmurti |
31 |
[GO] |
2021―Jun―22 |
The SARS-CoV-2 Spike Protein Subunit 1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells |
Ruben Colunga Biancatelli, Pavel Solopov, Elizabeth R Sharlow, John S Lazo, Paul Ellis Marik, John D Catravas |
32 |
[GO] |
2021―Jun―22 |
The significance of a lack of rhinorrhea in severe coronavirus 19 lung disease |
Michael Eisenhut |
33 |
[GO] |
2021―May―19 |
A Pilot Study to Assess the Circulating Renin-Angiotensin-System in COVID-19 Acute Respiratory Failure |
D. Clark Files, Kevin W. Gibbs, Christopher L. Schaich, Sean P. Collins, TanYa M. Gwathmey, Jonathan Dale Casey, et al. (+2) Wesley H. Self, Mark C. Chappell |
34 |
[GO] |
2021―May―12 |
The Oxygen Dissociation Curve of Blood in COVID-19 |
Dieter Böning, Wolfgang M. Kuebler, Wilhelm Bloch |
35 |
[GO] |
2021―May―05 |
The effect of estrogen in coronavirus disease 2019 (COVID-19) |
Qing Ma, Zhuo-wen Hao, Yan-feng Wang |
36 |
[GO] |
2021―Apr―06 |
In Silico investigation of the viroporin E as a vaccine target against SARS-CoV-2 |
Erasmia Rouka, Konstantinos I. Gourgoulianis, Sotirios G. Zarogiannis |
37 |
[GO] |
2021―Mar―24 |
Implications of pre-existing asthma on COVID-19 pathogenesis |
Rakhee K. Ramakrishnan, Saba Al Heialy, Qutayba Hamid |
38 |
[GO] |
2021―Mar―09 |
Molecular mechanisms of Na,K-ATPase dysregulation driving alveolar epithelial barrier failure in severe COVID-19 |
Vitalii Kryvenko, István Vadász |
39 |
[GO] |
2021―Feb―09 |
Carrageenan containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures |
Desiree Schütz, Carina Conzelmann, Giorgio Fois, Rüdiger Groß, Tatjana Weil, Lukas Wettstein, et al. (+6) Steffen Stenger, Alexander Zelikin, Thomas K Hoffmann, Manfred Frick, Janis A Müller, Jan Münch |
40 |
[GO] |
2021―Jan―12 |
SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport |
Reem Abdel Hameid, Estelle Cormet-Boyaka, Wolfgang M. Kuebler, Mohammed Uddin, Bakhrom K Berdiev |
41 |
[GO] |
2021―Jan―06 |
Remote ischemic conditioning for acute respiratory distress syndrome in COVID-19 |
Anthony V. Incognito, Philip J. Millar, W. Glen Pyle |
42 |
[GO] |
2021―Jan―06 |
Kinins and Chymase: The Forgotten Components of the Renin angiotensin system and their implications in COVID-19 Disease |
Zaid Abassi, Karl Skorecki, Dalit Ben Hamo-Giladi, Etty Kruzel-Davila, Samuel N Heyman |
43 |
[GO] |
2020―Dec―23 |
Healing after Covid-19: Are Survivors at Risk for Development of Pulmonary Fibrosis? |
Lindsay T McDonald |
44 |
[GO] |
2020―Dec―02 |
Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients. |
Ariana Centa, Aline S. Fonseca, Solange G. da Silva Ferreira, Marina Luise V. Azevedo, Caroline B. Vaz de Paula, Seigo Nagashima, et al. (+5) Cleber Machado-Souza, Anna Flavia R. dos Santos Miggiolaro, Cristina P. Baena, Lucia de Noronha, Luciane R. Cavalli |
45 |
[GO] |
2020―Nov―25 |
Immunoglobulin Deficiency as an Indicator of Disease Severity in Patients with COVID-19 |
Faeq Husain-Syed, István Vadász, Jochen Wilhelm, Hans-Dieter Walmrath, Werner Seeger, Horst-Walter Birk, et al. (+19) Birgit Jennert, Hartmut Dietrich, Susanne Herold, Janina Trauth, Khodr Tello, Michael Sander, Rory E. Morty, Heiko Slanina, Christian G. Schüttler, John Ziebuhr, Shadi Kassoumeh, Claudio Ronco, Fiorenza Ferrari, Klaus Warnatz, Klaus Stahl, Benjamin Seeliger, Marius M. Hoeper, Tobias Welte, Sascha David |
46 |
[GO] |
2020―Nov―25 |
Angiotensin-Converting Enzyme 2 and COVID-19: Patients, Comorbidities, and Therapies |
Girish Pathangey, Priyal Praful Fadadu, Alexandra Raye Hospodar, Amr Abbas |
47 |
[GO] |
2020―Nov―11 |
Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections |
Mathew Suji Eapen, Wenying Lu, Tillie-Louise Hackett, Gurpreet K Singhera, Isobel E. Thompson, Kielan Darcy McAlinden, et al. (+6) Ashutosh Hardikar, Heinrich C. Weber, Greg Haug, Peter A. B. Wark, Collin Chia, Sukhwinder Singh Sohal |
48 |
[GO] |
2020―Nov―04 |
High-dimensional single-cell analysis reveals the immune characteristics of COVID-19 |
Wen Shi, Xiuxing Liu, Qiqi Cao, Pengjuan Ma, Wenqing Le, Lihui Xie, et al. (+6) JinGuo Ye, Wen Wen, Hao Tang, Wenru Su, Yingfeng Zheng, Yizhi Liu |
49 |
[GO] |
2020―Oct―28 |
Angiotensin-converting enzyme 2 (ACE2) expression in COPD and IPF fibroblasts- the forgotten cell in COVID-19 |
Noof Aloufi, Hussein Traboulsi, Jun Ding, Gregory J Fonseca, Parameswaran Nair, Steven K. Huang, et al. (+3) Sabah N. A. Hussain, David H. Eidelman, Carolyn J Baglole |
50 |
[GO] |
2020―Oct―14 |
Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19 |
Dusan Hanidziar, Simon C Robson |
51 |
[GO] |
2020―Sep―30 |
Pneumonia in the face of COVID-19 |
Martin Witzenrath, Wolfgang Michael Kuebler |
52 |
[GO] |
2020―Sep―30 |
VITAMIN D SUPPLEMENTATION AS A RATIONAL PHARMACOLOGICAL APPROACH IN THE COVID-19 PANDEMIC |
Leon Ferder, Virna Margarita Martín Giménez, Felipe Inserra, Carlos Tajer, Laura Antonietti, Javier Mariani, Walter Manucha |
53 |
[GO] |
2020―Sep―30 |
Sex steroids skew ACE2 expression in human airway: A contributing factor to sex differences in COVID-19? |
Rama Satyanarayana Raju Kalidhindi, Niyati A Borkar, Nilesh Sudhakar Ambhore, Christina M Pabelick, YS Prakash, Venkatachalem Sathish |
54 |
[GO] |
2020―Sep―30 |
"World Pneumonia Day During a Global Pneumonia Pandemic: 12 November 2020" |
Leith Greenslade |
55 |
[GO] |
2020―Sep―09 |
Human coronaviruses 229E and OC43 replicate and induce distinct anti-viral responses in differentiated primary human bronchial epithelial cells |
Su-Ling Loo, Peter A. B. Wark, Camille Esneau, Kristy S Nichol, Alan C-Y Hsu, Nathan W Bartlett |
56 |
[GO] |
2020―Sep―03 |
Elevated FiO2 increases SARS-CoV-2 co-receptor expression in respiratory tract epithelium |
Despoina Myti, Miša Gunjak, Francisco Casado, Solmaz Khaghani Raziabad, Claudio Nardiello, István Vadász, et al. (+4) Susanne Herold, Gloria S Pryhuber, Werner Seeger, Rory E. Morty |
57 |
[GO] |
2020―Aug―12 |
Role of the renin angiotensin system in the development of severe COVID-19 in hypertensive patients |
Rodrigo Pacheco Silva-Aguiar, Diogo de Barros Peruchetti, Patricia Rieken Macedo Rocco, Alvin H Schmaier, Patricia Machado Rodrigues Silva, Marco Aurélio Martins, et al. (+3) Vinicius de Frias Carvalho, Ana Acacia Sa Pinheiro, Celso Caruso-Neves |
58 |
[GO] |
2020―Aug―05 |
The potential role of the Carotid Body in COVID-19 |
Andrea Porzionato, Aron Emmi, Elena Stocco, Silvia Barbon, Rafael Boscolo-Berto, Veronica Macchi, Raffaele De Caro |
59 |
[GO] |
2020―Aug―05 |
SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs |
Rafal Bartoszewski, Michal Dabrowski, Bogdan Jakiela, Sadis Matalon, Kevin S. Harrod, Marek Sanak, James F. Collawn |
60 |
[GO] |
2020―Jul―22 |
Is there an association between the level of ambient air pollution and COVID-19? |
Baoming Wang, Hui Chen, Yik Lung Chan, Brian G. Oliver |
61 |
[GO] |
2020―Jul―15 |
SARS-CoV-2 (COVID-19) and Cystic Fibrosis |
Bruce A Stanton, Thomas H Hampton, Alix Ashare |
62 |
[GO] |
2020―Jul―08 |
DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY |
Riccardo Sarzani, Federico Giulietti, Chiara Di Pentima, Piero Giordano, Francesco Spannella |
63 |
[GO] |
2020―Jun―17 |
NOVEL INSIGHTS ON THE PULMONARY VASCULAR CONSEQUENCES OF COVID-19 |
Francois Potus, Vicky Mai, Marius Lebret, Simon Malenfant, Emilie Breton-Gagnon, Annie C Lajoie, et al. (+3) Olivier Boucherat, Sebastien Bonnet, Steeve Provencher |
64 |
[GO] |
2020―Jun―17 |
Assessment of ACE inhibitors/angiotensin receptor blockers in COVID-19 patients |
Krishna Sriram, Paul A. Insel |
65 |
[GO] |
2020―Jun―17 |
Potential role for nitazoxanide in treating SARS-CoV-2 infection |
Paulo Ricardo Martins-Filho, José Antônio Barreto-Alves, Ricardo Fakhouri |
66 |
[GO] |
2020―Jun―10 |
Consideration of Pannexin 1 channels in COVID-19 pathology and treatment |
Leigh Anne Swayne, Scott R Johnstone, Chen Seng Ng, Juan C Sanchez-Arias, Miranda E Good, Silvia Penuela, et al. (+5) Alexander W Lohman, Abigail G Wolpe, Victor E. Laubach, Michael Koval, Brant E. Isakson |
67 |
[GO] |
2020―Jun―10 |
Is targeting Akt a viable option to treat advanced-stage COVID-19 patients? |
Payaningal R Somanath |
68 |
[GO] |
2020―Jun―10 |
Heparin as a Therapy for COVID-19: Current Evidence and Future Possibilities. |
Joseph Alan Hippensteel, Wells B LaRiviere, James F Colbert, Christophe J Langouët-Astrié, Eric P. Schmidt |
69 |
[GO] |
2020―Jun―04 |
Thoughts on the alveolar phase of COVID-19 |
Robert J. Mason |
70 |
[GO] |
2020―Jun―03 |
Understanding the age divide in COVID-19: Why are children overwhelmingly spared? |
Krithika Lingappan, Harry Karmouty-Quintana, Jonathan Davies, Bindu Akkanti, Matthew T Harting |
71 |
[GO] |
2020―May―28 |
P-selectin blockade in COVID-19-related ARDS |
Tommaso Neri, Dario Nieri, Alessandro Celi |
72 |
[GO] |
2020―May―20 |
Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells |
Kimberly E Stelzig, Fabrizio Canepa-Escaro, Marta Schiliro, Sergejs Berdnikovs, Y S Prakash, Sergio E Chiarella |
73 |
[GO] |
2020―May―13 |
Treatment of COVID-19 exacerbated asthma: should systemic corticosteroids be used? |
Kartik Kumar, Timothy SC Hinks, Aran Singanayagam |
74 |
[GO] |
2020―May―13 |
Urgent reconsideration of lung edema as a preventable outcome in COVID-19: Inhibition of TRPV4 represents a promising and feasible approach |
Wolfgang Michael Kuebler, Sven-Eric Jordt, Wolfgang B. Liedtke |
75 |
[GO] |
2020―May―04 |
Don’t judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19 |
Thomas Walther, Wolfgang M. Kuebler |
76 |
[GO] |
2020―May―04 |
Rigor before speculation in COVID-19 therapy |
Paul A. Welling, Daniel Batlle, James Brian Byrd, Louise M. Burrell, Andrew M. South, Matthew A. Sparks |
77 |
[GO] |
2020―May―04 |
Reply to Letter to the Editor: “Don’t judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19” |
Zaid A. Abassi, Karl Skorecki, Samuel N. Heyman, Safa Kinaneh, Zaher Armaly |
78 |
[GO] |
2020―Apr―08 |
Call for Papers: The pathophysiology of COVID-19 and SARS-CoV-2 infection |
Rory E. Morty, John Ziebuhr |
79 |
[GO] |
2020―Apr―01 |
COVID-19 - is the ACE2 just a foe? |
Hrvoje Jakovac |
80 |
[GO] |
2020―Mar―24 |
Covid-19 infection and mortality - A physiologist's perspective enlightening clinical features and plausible interventional strategies |
Zaid A. Abassi, Karl Skorecki, Samuel Noam Heyman, Safa Kinaneh, Zaher Armaly |